TIL - Trilogy [formerly ECO - Ecoya]

[Blendy]

key events this year:
ASX listing by end October
Rosehip supplier acquisition
Capital raising

(All things we know)

[Blendy]

FY16 will always be considered a stand out year

[Blendy]

The revenue from distribution (CS&co acquisition) is worth more than revenue from Ecoya

[Blendy]

New Rosehip range released in October.

Driving more market share in NZ and Australia via distribution.

China and Korea are key markets, but can't be registered in China as they require animal testing but TIL are against this. Partnering with a company that can help with sales in this area.

[Blendy]

They want to own the new Chia seed market, just as they do with Rosehip.

That's a good focus, I feel.

[stevevai1983]

little bit disappoint about the F17 guidance. my own estimates was 117m.
F17 100~110m means if we exclude CS&Co there is not much growth left..

[Snow Leopard]

AGM stuff: https://nzx.com/companies/TIL/announcements/289571

Forecasts: https://nzx.com/companies/TIL/announcements/289572

to complement the live streaming from our reporter at the scene.

Best Wishes
Paper Tiger

[winner69]

Hope market isn't as disappointed with that guidance as I am

[Blendy]

Ecoya: focus on limited edition ranges to grow seasonal sales. Last years Christmas range contributed 10% of total revenue.

[boysy]

Yep market not liking the outlook let's hope they have undercooked the growth figures again